Sale to Clayton, Dubilier & Rice, LLC

Healthcare
Sale to Clayton, Dubilier & Rice, LLC

Summary

Baird served as exclusive financial advisor to Drive DeVilbiss Healthcare on this transaction

About

Drive DeVilbiss Healthcare (“Drive” or the “Company”), a portfolio company of Ferrer Freeman & Company, LLC (“FFC”), was recently acquired by Clayton, Dubilier & Rice, LLC. (“CD&R”). Terms of the transaction were not disclosed.

Drive DeVilbiss Healthcare manufactures a complete line of medical products, including mobility products, sleep and respiratory products, beds, bariatric products, wheelchairs, sleep surfaces and pressure prevention products, self-assist products, power operated wheelchairs, rehabilitation products, patient room equipment, personal care products and electrotherapy devices. Currently, the Company has corporate offices, manufacturing facilities and distribution facilities in the United States, Canada, the United Kingdom, France, Germany, China, Hong Kong, Romania, Australia, the Netherlands and India. The Company markets its products to customers located throughout the United States, Europe, Canada, Mexico, South America, Latin America, the Middle East and Asia. The Company is headquartered in Port Washington, New York.

Ferrer Freeman & Company, LLC is a private equity firm focused on making growth capital investments in healthcare companies. Since its founding in 1995, FFC has invested over $900 million in 36 portfolio companies. FFC invests in established companies in the middle market with significant growth opportunities, backs proven management teams, and then leverages its comprehensive healthcare network and value creation model to accelerate growth and build market leading and strategically valuable companies. FFC is headquartered in Greenwich, Connecticut.

Founded in 1978, Clayton, Dubilier & Rice is a private investment firm. Since inception, CD&R has managed the investment of $22 billion in 70 companies representing a broad range of industries with an aggregate transaction value of more than $100 billion. CD&R’s healthcare-related investments include VWR International, a provider of laboratory products and services; AssuraMed, a distributor of specialty medical products into the home; Envision Healthcare, a provider of facility-based physician services and medical transportation services; PharMEDium, a provider of hospital pharmacy-outsourced sterile compounding services; Healogics, a provider of advanced wound care services; and Vets First Choice, a provider of pharmacy and other value-added services for veterinary practices. CD&R has offices in New York City, New York and London, England. CD&R is headquartered in New York City, New York.
CONTACT US TO LEARN MORE
Healthcare
Sale to Clayton, Dubilier & Rice, LLC
Date
January 2017
Company
Drive DeVilbiss Healthcare
Transaction
M&A
Sectors
Healthcare
Target Location
North America
Acquiror Location
North America

Share